Ouahed, J., Kelsen, J. R., Spessott, W. A., Kooshesh, K., Sanmillan, M. L., Dawany, N., Sullivan, K. E., Hamilton, K. E., Slowik, V., Nejentsev, S., Neves, J. F., Flores, H., Chung, W. K., Wilson, A., Anyane-Yeboa, K., Wou, K., Jain, P., Field, M., Tollefson, S., Dent, M. H., Li, D., Naito, T., McGovern, D. P. B., Kwong, A. C., Taliaferro, F., Ordovas-Montanes, J., Horwitz, B. H., Kotlarz, D., Klein, C., Evans, J., Dorsey, J., Warner, N., Elkadri, A., Muise, A. M., Goldsmith, J., Thompson, B., Engelhardt, K. R., Cant, A. J., Hambleton, S., Barclay, A., Toth-Petroczy, A., Vuzman, D., Carmichael, N., Bodea, C., Cassa, C. A., Devoto, M., Maas, R. L., Behrens, E. M., Giraudo, C. G., & Snapper, S. B. (2021). variants in STXBP3 are Associated with Very Early Onset Inflammatory Bowel Disease, Bilateral Sensorineural Hearing Loss and Immune Dysregulation. Journal of Crohn's and colitis, 15, 1908–1919. http://access.bl.uk/ark:/81055/vdc_100145636914.0x000006